Tilak Healthcare Raises €10 Million to Expand Ophthalmological Telemedicine Offering

Tilak Healthcare, a pioneer in the field of ophthalmological digital health, has secured €10 million in funding led by Elaia and Cap Horn. The company, known for its leading telemedicine platform OdySight, aims to revolutionize ophthalmological care through the use of digital technologies and video games. With this new funding, Tilak Healthcare plans to accelerate the expansion of OdySight in France and internationally, as well as develop new solutions for other medical conditions.

OdySight is a remote monitoring system for ophthalmic conditions that incorporates a gaming interface to encourage consistent patient use. It has been particularly effective in improving the care of patients suffering from retinal diseases such as age-related macular degeneration and diabetic retinopathy, allowing ophthalmologists to monitor patients' visual acuity in real-time. The French social security system finances OdySight under the government's 'Article 51' scheme for experimental technologies.

The recent investment by Théa, Europe's leading independent ophthalmology laboratory, highlights the value and importance of OdySight in the field of visual health applications. The extended collaboration between Tilak Healthcare and Théa aims to unleash new opportunities for healthcare professionals and patients alike.

According to the World Health Organization, an estimated 3.4 billion people worldwide will be affected by visual impairment by 2030. Many of these cases could have been prevented or addressed with proper medical care. Tilak Healthcare developed OdySight in response to this growing need. By combining a medical device with a mobile video game, OdySight offers a unique solution for remotely monitoring age-related vision impairments. Since its launch, OdySight has already made a significant impact, improving the lives of 12,000 patients in Europe.

Edouard Gasser, Chairman, CEO, and co-founder of Tilak Healthcare, expressed his pride in the recent funding round and welcomed the new investors who share the company's vision of revolutionizing ophthalmological care. Gasser emphasized the importance of visual health in aging well and Tilak Healthcare's commitment to helping people maintain their vision. The company aims to become a global benchmark for remotely monitoring vision impairments.

Investors Elaia Partners and Cap Horn expressed their confidence in Tilak Healthcare's potential to transform the care of patients with chronic eye disorders. They recognized the clinical utility of OdySight in monitoring these conditions and its shift towards preventive care. The investors were particularly impressed with Tilak Healthcare's business model, which has shown significant momentum and growth.

Théa, a major player in the ophthalmology industry, underscored its support for Tilak Healthcare and its commitment to innovative solutions that benefit both patients and healthcare professionals. Théa aims to eliminate avoidable blindness and improve the quality of life for individuals with eye disorders.

Tilak Healthcare's team is led by Edouard Gasser, a former studio manager at Gameloft, and guided by experts with extensive experience in designing video games and world-renowned scientists. This unique combination of skills allows Tilak Healthcare to create engaging solutions that meet the clinical demands of medical professionals.

The funding round was supported by Clipperton, acting as Tilak Healthcare's sole financial advisor. The company is well-positioned to achieve its goals and continue its mission of transforming ophthalmological care through digital technologies and video games.

Tilak Healthcare's impressive progress and commitment to delivering high-quality healthcare solutions have attracted a diverse set of investors, demonstrating the company's strong potential for growth and innovation in the field of telemedicine. With its continued focus on improving visual health and expanding its offerings, Tilak Healthcare is poised to make a lasting impact on the lives of millions affected by visual impairments.